An Additional LDL-Lowering Effect of Amlodipine; Not Only an Antihypertensive?

Author： Arslan Zekeriya   Ay Seyit Ahmet   Karaman Murat   Cakar Mustafa   Celik Turgay   Balta Sevket   Akhan Muharrem   Sarlak Hakan   Arslan Erol   Demirbas Seref   Demirkol Sait   Bulucu Fatih   Saglam Kenan  

Publisher： Informa Healthcare

ISSN： 1064-1963

Source： Clinical and Experimental Hypertension, Vol.35, Iss.6, 2013-10, pp. : 449-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adding ezetimibe to statin treatment: is LDL-C lowering the only benefit?

By Kostapanos Michael S   Mikhailidis Dimitri P   Elisaf Moses S  

Future Cardiology, Vol. 8, Iss. 6, 2012-11 ,pp. : 813-817

Future Medicine

Access to resources Recommend Favorite

Prolonged Antihypertensive Effect of Amlodipine: a Prospective Double-Blind Randomized Study

By BISTON P.   MÉLOT C.   DEGAUTE J. P.   CLEMENT D.   QUOIDBACH A.  

Blood Pressure, Vol. 8, Iss. 1, 1999-05 ,pp. : 43-48

Informa Healthcare

Access to resources Recommend Favorite

Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients

By Wu San-Chiang   Liu Chun-Peng   Chiang Hung-Ting   Lin Shoa-Lin  

Heart and Vessels, Vol. 19, Iss. 1, 2004-01 ,pp. : 13-18

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 820-830

Bentham Science Publishers

Access to resources Recommend Favorite

Glucose and LDL Lowering: The Need for Intensive Therapy

By  

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-01 ,pp. : 687-689

Bentham Science Publishers

Access to resources Recommend Favorite